Filter
7275
Filtered Results: 7275
Text search:
Partners
in
Health,
World
Health
Organization
Featured
Recommendations
628
New Publications
2090
Language
Document type
No document type
4170
Studies & Reports
1186
Guidelines
821
Manuals
377
Strategic & Response Plan
332
Fact sheets
121
Training Material
110
Situation Updates
86
Resource Platforms
27
Infographics
16
Brochures
15
Online Courses
6
Videos
5
App
2
Dashboards/Maps
1
Countries / Regions
Global
318
India
238
Kenya
227
Sierra Leone
188
Uganda
175
Ethiopia
172
Nigeria
165
Liberia
157
Nepal
138
Myanmar / Burma
127
Zambia
121
South Africa
115
Rwanda
114
Bangladesh
109
Malawi
108
Syria
106
Africa
106
Tanzania
106
Western and Central Europe
104
Ghana
93
Ukraine
82
Congo, Democratic Republic of
81
South Sudan
76
Namibia
74
Latin America and the Carribbean
69
Philippines
66
Lesotho
56
Zimbabwe
56
Cambodia
54
South–East Asia Region
50
Guinea
49
Indonesia
48
Mozambique
47
Asia
47
Haiti
45
Yemen
42
Eastern Europe
41
Senegal
39
East and Southern Africa
38
West and Central Africa
37
Cameroon
34
Afghanistan
32
Botswana
31
Middle East and North Africa
30
Burkina Faso
28
Germany
28
Pakistan
26
Russia
24
Central African Republic
24
Somalia
23
Jordan
20
Lebanon
20
Eswatini/ Swaziland
20
Brazil
19
Mali
19
Thailand
18
Venezuela
18
Western Pacific Region
17
Sudan
17
Madagascar
17
Benin
15
Eastern Europe and Central Asia
15
Iraq
15
Colombia
14
Vietnam
14
Tajikistan
13
Laos
12
Moldova
12
Sri Lanka
12
China
10
Albania
10
Côte d’Ivoire / Ivory Coast
10
Georgia
9
Angola
9
Libya
9
Turkey
8
Togo
8
Niger
8
Chad
8
North Macedonia
7
Timor Leste/ East Timor
7
Gambia
7
Iran
7
Burundi
7
Peru
6
USA
6
North America
6
Palestine
6
Mexico
5
Kyrgyzstan
5
Guinea-Bissau
5
Jamaica
5
Papua New Guinea
5
Egypt
5
Greece
5
Poland
5
Serbia
4
Kazakhstan
4
Armenia
4
Turkmenistan
4
Japan
4
Southern Africa
4
Romania
4
Honduras
4
El Salvador
3
Malaysia
3
Morocco
3
Mauritania
3
Croatia
3
Hungary
3
Paraguay
3
Mauritius
3
Tunisia
3
Portugal
3
Spain
3
Belarus
3
Bhutan
3
Guatemala
3
North Korea
2
Switzerland
2
Canada
2
Bulgaria
2
Italy
2
Dominican Republic
2
Saudi Arabia
2
United Kingdom
2
Azerbaijan
2
Israel
2
Bolivia
2
Argentina
2
Djibouti
2
Chile
1
Fiji
1
Singapore
1
Estonia
1
Uzbekistan
1
Austria
1
Vanuatu
1
Mongolia
1
Qatar
1
Cape Verde
1
Lithuania
1
Gabon
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
Algeria
1
Bosnia and Herzegovina
1
Latvia
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Slovakia
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2730
Key Resources
489
Clinical Guidelines
425
Women & Child Health
418
Public Health
363
Capacity Building
133
Pharmacy & Technologies
45
Annual Report MEDBOX
3
Toolboxes
HIV
694
COVID-19
491
Mental Health
433
TB
342
Disability
305
Conflict
263
Ebola & Marburg
248
Planetary Health
232
NTDs
185
Caregiver
175
AMR
169
Rapid Response
155
Refugee
149
Global Health Education
143
Health Financing Toolbox
105
Natural Hazards
100
Pharmacy
84
2.0 Rapid Response
83
Malaria
81
Zika
75
NCDs
73
Cholera
58
Polio
42
Specific Hazards
26
Social Ethics
22
Typhoon
3
South Sudan
2
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside reverse-transcriptase inhibitors (NNRTI) can affect more than 10% of adults starting therapy and is fo...
Enabling young children to achieve their full developmental potential is a human right and an essential requisite for sustainable development. Given the critical importance of enabling children to make the best start in life, the health sector, among other sectors, has an important role and responsi...
Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report.
In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available...
Mpox, previously known as monkeypox, is a viral illness caused by the monkeypox virus (MPXV).1
It causes a painful rash, enlarged lymph nodes, fever, headache, muscle ache, back pain and low energy or feeling sick. In most cases, the symptoms of mpox go away within a few weeks with supportive care...
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite...
Antimicrobial Resistance Resource Platform
recommended
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.
AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections ha...
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and interpret their test result themselves at a time a...
Zika virus is primarily transmitted by the Aedes species of mosquito which is also responsible for the spread of dengue, Chikungunya and yellow fever viruses. In most areas, the primary vector of these viruses is Aedes aegypti, with Aedes albopictus a proven or potential vector in some settings. Wel...
This document provides interim recommendations for the surveillance of Zika virus infection, microcephaly and Guillain-Barré syndrome, in four different contexts and describes reporting requirements to WHO. Transmission refers to vector-borne transmission, unless specified differently. Autochthonou...
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Novel coronavirus will disproportionately impact world’s 70 million displaced people
Report recommends stopping asylum seeker deportations, prioritising hygiene and refugee camp decongestion, better communication
Displaced people must be included in prevention, mitigation efforts - for s...
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries face challenges with erratic vaccine supplies, use of multiple vaccine products with different charact...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec...
People-centered approaches that help communities maintain protective behaviours and follow guidelines set out by public health and government agencies are more important than ever. The evidence is clear, communities play a role in preventing and controlling epidemics and they are best able to take a...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
